PHGDH acts on serine biosynthesis, and the inhibition of PHGDH was proposed to treat epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant lung adenocarcinoma (28). This evidence concerns the gene PHGDH and lung adenocarcinoma.